| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
3 companies
Kozarich John W is a Director at LGNYZ, with reported holdings spanning 3 companies. Recent filings cover 0 purchases and 80 sales. Those positions are worth an estimated $2.9M at current prices.
Our model assigns Kozarich John W a below-average insider score of 48/100, based on 16 past trades. Over a 12-month horizon, 33.3% of those trades were profitable, with an average 12-month return of -36.9%.
Kozarich John W's largest disclosed position is in LGND as Director, worth about $2.9M. The recent filings there lean toward selling, a net 50,230 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Sep 7, 2016 | LGND Ligand Pharmaceuticals Inc | Director | Sell | 1,000 | $115.00 | $115,000.00 | -2.4% | |
| Sep 1, 2016 | LGND Ligand Pharmaceuticals Inc | Director | Sell | 1,666 | $105.40 | $175,596.80 | -4.1% | |
| Aug 1, 2016 | LGND Ligand Pharmaceuticals Inc | Director | Sell | 1,000 | $137.57 | $137,569.00 | -2.4% | |
| Jul 1, 2016 | LGND Ligand Pharmaceuticals Inc | Director | Sell | 1,000 | $121.40 | $121,402.00 | -2.3% | |
| Jun 1, 2016 | LGND Ligand Pharmaceuticals Inc | Director | Sell | 1,000 | $117.42 | $117,419.00 | -2.3% | |
| May 2, 2016 | LGND Ligand Pharmaceuticals Inc | Director | Sell | 1,000 | $121.57 | $121,568.00 | -2.2% | |
| Apr 6, 2016 | LGND Ligand Pharmaceuticals Inc | Director | Sell | 5,000 | $115.00 | $575,000.00 | -10.1% | |
| Jan 20, 2016 | LGND Ligand Pharmaceuticals Inc | Director | Sale+OE | 1,666 | $94.94 | $158,173.34 | -3.2% |